Introduction to chemosensitive profiling 11 2020 EDITED V1

Drug discovery research and development in oncology aims to identify medicines that can maximise patient survival. Once treatment is initiated in cancer patients, drug resistance can be a limiting factor to achieving a cure. This can be overcome by the combined administration of drugs with non-overlapping mechanisms of action (poly-chemotherapy). In order to achieve this, chemosensitivity assays are required. This webinar will discuss the following topics:

1. Overview of cell-based assay systems.
2. Adapting cell-based assay systems for chemosensitivity assays.
3. Case studies of chemosensitivity assays.

Speaker: Dr Sheraz Gul (Head of Assay Development & Screening, Fraunhofer IME ScreeningPort, Hamburg)

Скачать видео